John J. Oppenheimer
CIK: 0002087669
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BIAF
bioAffinity Technologies, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Oppenheimer John J.
Oppenheimer John J. (SEC CIK 0002087669) files insider reports with the SEC as Director of bioAffinity Technologies, Inc. (BIAF).
Signal8 holds 1 ownership filing by Oppenheimer John J., a Form 3, filed on Sep 25, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Oppenheimer John J.'s filings is in SAN ANTONIO,, TX.
Other insiders filing for bioAffinity Technologies, Inc. (BIAF)
- Rios Roberto, Director
- Reveles Xavier Trinidad, Chief Operating Officer
- GIRGENTI STEVEN, Executive Chairman
- Zannes Maria, President & CEO
- Edwards James Michael, VP and CFO
- Zannes Timothy P, Secretary, EVP, Gen. Counsel